<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2023.1113401</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Inhibitory effects of vaginal <italic>Lactobacilli</italic> on C<italic>andida albicans</italic> growth, hyphal formation, biofilm development, and epithelial cell adhesion</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Takano</surname><given-names>Tomonori</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2121031"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kudo</surname><given-names>Hayami</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1371073"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eguchi</surname><given-names>Shuhei</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2122633"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matsumoto</surname><given-names>Asami</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1286383"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Oka</surname><given-names>Kentaro</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/187185"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yamasaki</surname><given-names>Yukitaka</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takahashi</surname><given-names>Motomichi</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/175079"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koshikawa</surname><given-names>Takuro</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takemura</surname><given-names>Hiromu</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yamagishi</surname><given-names>Yuka</given-names>
</name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mikamo</surname><given-names>Hiroshige</given-names>
</name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/519958"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kunishima</surname><given-names>Hiroyuki</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>*</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2122608"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Infectious Diseases, St. Marianna University School of Medicine</institution>, <addr-line>Kawasaki-shi, Kanagawa</addr-line>, <country>Japan</country></aff>
<aff id="aff2"><sup>2</sup><institution>Research Department, R&amp;D Division, Miyarisan Pharmaceutical Co., Ltd.</institution>, <addr-line>Saitama-shi, Saitama</addr-line>, <country>Japan</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Microbiology, St. Marianna University School of Medicine</institution>, <addr-line>Kawasaki-shi</addr-line>, <country>Japan</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Clinical Infectious Diseases, Aichi Medical University</institution>, <addr-line>Nagakute, Aichi</addr-line>, <country>Japan</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Clinical Infectious Diseases, Kochi Medical School</institution>, <addr-line>Nankoku-shi, Kochi</addr-line>, <country>Japan</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Maria Gabriela Paraje, National University of Cordoba, Argentina</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Val&#xe9;rio Monteiro-Neto, Universidade Federal do Maranh&#xe3;o, Brazil; Linda S. Archambault, UCONN Health, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Hiroyuki Kunishima, <email xlink:href="mailto:h2kuni@marianna-u.ac.jp">h2kuni@marianna-u.ac.jp</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>05</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>13</volume>
<elocation-id>1113401</elocation-id>
<history>
<date date-type="received">
<day>01</day>
<month>12</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>04</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Takano, Kudo, Eguchi, Matsumoto, Oka, Yamasaki, Takahashi, Koshikawa, Takemura, Yamagishi, Mikamo and Kunishima</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Takano, Kudo, Eguchi, Matsumoto, Oka, Yamasaki, Takahashi, Koshikawa, Takemura, Yamagishi, Mikamo and Kunishima</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Antifungal agents are not always efficient in resolving vulvovaginal candidiasis (VVC), a common genital infection caused by the overgrowth of <italic>Candida</italic> spp., including <italic>Candida albicans</italic>, or in preventing recurrent infections. Although lactobacilli (which are dominant microorganisms constituting healthy human vaginal microbiota) are important barriers against VVC, the <italic>Lactobacillus</italic> metabolite concentration needed to suppress VVC is unknown.</p>
</sec> <sec>
<title>Methods</title> <p>We quantitatively evaluated <italic>Lactobacillus</italic> metabolite concentrations to determine their effect on <italic>Candida</italic> spp., including 27 vaginal strains of <italic>Lactobacillus crispatus, L. jensenii, L. gasseri, Lacticaseibacillus rhamnosus</italic>, and <italic>Limosilactobacillus vaginalis</italic>, with inhibitory abilities against biofilms of <italic>C. albicans</italic> clinical isolates.</p>
</sec>
<sec>
<title>Results</title>
<p><italic>Lactobacillus</italic> culture supernatants suppressed viable fungi by approximately 24%-92% relative to preformed <italic>C. albicans</italic> biofilms; however, their suppression differed among strains and not species. A moderate negative correlation was found between <italic>Lactobacillus</italic> lactate production and biofilm formation, but no correlation was observed between hydrogen peroxide production and biofilm formation. Both lactate and hydrogen peroxide were required to suppress <italic>C. albicans</italic> planktonic cell growth. <italic>Lactobacillus</italic> strains that significantly inhibited biofilm formation in culture supernatant also inhibited <italic>C. albicans</italic> adhesion to epithelial cells in an actual live bacterial adhesion competition test.</p>
</sec>
<sec>
<title>Discussion </title>
<p>Healthy human microflora and their metabolites may play important roles in the development of new antifungal agent against <italic>C. albicans</italic>-induced VVC.</p>
</sec>
</abstract>
<kwd-group>
<kwd><italic>Candida albicans</italic>
</kwd>
<kwd><italic>Lactobacillus</italic> species</kwd>
<kwd>biofilm</kwd>
<kwd>probiotics</kwd>
<kwd>cell adhesion</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="52"/>
<page-count count="11"/>
<word-count count="6402"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Biofilms</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Fungal diseases cause considerable morbidity and mortality, resulting in a high economic burden (<xref ref-type="bibr" rid="B12">Drgona et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B5">Bongomin et&#xa0;al., 2017</xref>). Vulvovaginal candidiasis (VVC), a common genital infection, is commonly caused by <italic>Candida albicans</italic>, with a lifetime prevalence of up to 78% in women (<xref ref-type="bibr" rid="B52">Yano et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Willems et&#xa0;al., 2020</xref>). Eight percent of women with VVC experience recurrent VVC (RVVC), which relapses more than four times a year due to the low response to antifungal treatment, including the use of azoles such as fluconazole (<xref ref-type="bibr" rid="B11">Denning et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B8">Cooke et&#xa0;al., 2022</xref>). The highest prevalence of RVVC occurs among 25-34-year-olds, and it has an annual economic burden of US$14-39 billion in developed countries because it reduces the quality of life (<xref ref-type="bibr" rid="B11">Denning et&#xa0;al., 2018</xref>). The emergence and spread of antimicrobial resistance (AMR) have become a global concern, and fungal infections have been excluded from the AMR program (<xref ref-type="bibr" rid="B13">Fisher et&#xa0;al., 2022</xref>). However, as with bacterial infections, the use of antifungal drugs is strongly implicated in the occurrence of pathogenic fungi, and thus new methods of prevention or treatment of RVVC that are not dependent on antifungal use are required (<xref ref-type="bibr" rid="B26">Matsubara et&#xa0;al., 2016</xref>).</p>
<p><italic>C. albicans</italic> is a dimorphic fungus that can transform from yeast to an invasive filamentous hyphal form (<xref ref-type="bibr" rid="B45">Sudbery, 2011</xref>; <xref ref-type="bibr" rid="B49">Willems et&#xa0;al., 2020</xref>). Biofilm formation by <italic>C. albicans</italic> commonly consists of four major stages: yeast cells adhere to a substrate to form a yeast basal layer; initiation of propagating cells where the hyphae are formed; hypha formation and extracellular matrix accumulation with extracellular polysaccharides, structural proteins, cell debris, and nucleic acids; and dispersion of yeast cells from the biofilm to initiate biofilms at new locations (<xref ref-type="bibr" rid="B6">Chandra and Mukherjee, 2015</xref>). These biofilm structures are intrinsically resistant to antifungals, making VVC difficult to combat (<xref ref-type="bibr" rid="B43">Silva et&#xa0;al., 2017</xref>).</p>
<p>The vaginal microbiota of humans is known to be less complex than the intestinal microbiota and is usually dominated by the genus <italic>Lactobacillus</italic> (<xref ref-type="bibr" rid="B28">Matsumoto et&#xa0;al., 2018</xref>). The disruption of this vaginal microbiota promotes colonization by pathogenic microorganisms that leads to bacterial vaginosis and subsequent VVC (<xref ref-type="bibr" rid="B35">Ravel et&#xa0;al., 2013</xref>). With recent progress in sequencing technology, the presence of certain lactobacilli has been found to be associated with vaginal health. <italic>Lactobacillus crispatus</italic>-and <italic>L. jensenii</italic>-dominated vaginal microbiota are strongly associated with vaginal health (<xref ref-type="bibr" rid="B7">Chee et&#xa0;al., 2020</xref>). Furthermore, a <italic>L. iners</italic>-dominated environment could be affected by vaginal dysbiosis (<xref ref-type="bibr" rid="B7">Chee et&#xa0;al., 2020</xref>). These species contribute to vaginal homeostasis mainly by producing metabolites, including lactate and hydrogen peroxide, although their production abilities vary among isolates of the same species (<xref ref-type="bibr" rid="B50">Witkin et&#xa0;al., 2013</xref>).</p>
<p>In previous studies, production of lactate and hydrogen peroxide has been evaluated using a qualitative method (<xref ref-type="bibr" rid="B26">Matsubara et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B37">Ribeiro et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B47">Wang et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B1">Aarti et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B40">Rossoni et&#xa0;al., 2018</xref>). However, studies on quantitative evaluation of the metabolite are insufficient. This study aimed to quantitatively evaluate the metabolites of lactobacilli to determine the effects of lactobacilli on <italic>C. albicans</italic> growth, hyphal formation, biofilm development, and epithelial cell adhesion.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Strains</title>
<p>Forty-five <italic>C. albicans</italic> strains, which were clinically isolated from the vagina and provided by Microskylab Inc. (Tokyo, Japan), were used in this study. All 27 <italic>Lactobacillus</italic> strains were previously obtained from vaginal swabs of healthy Japanese women at Aichi Medical University (<xref ref-type="bibr" rid="B28">Matsumoto et&#xa0;al., 2018</xref>). These strains belonged to five species: <italic>L. crispatus</italic>, <italic>L. jensenii</italic>, <italic>L. gasseri</italic>, <italic>Lacticaseibacillus rhamnosus</italic>, and <italic>Limosilactobacillus vaginalis</italic>. The characteristics of these bacterial strains are listed in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;1</bold></xref>.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Biofilm formation and quantification</title>
<p>A 96-well microtiter plate-based method was used in this study (<xref ref-type="bibr" rid="B24">Lohse et&#xa0;al., 2018</xref>). <italic>C. albicans</italic> strains were cultured for 24&#xa0;h in Yeast Peptone Dextrose (YPD) agar (Difco, Detroit, MI, USA) at 30&#xb0;C under aerobic conditions. A single colony was inoculated into the YPD broth medium and incubated overnight for 16&#xa0;h at 30&#xb0;C, accompanied with shaking at 160 rpm under aerobic conditions. Under these conditions, <italic>C. albicans</italic> strains grew to the budding yeast forms (blastospores). The cells were centrifuged at 3,500 &#xd7;g for 10&#xa0;min and re-suspended in RPMI 1640 medium buffered with morpholinepropanesulfonic acid (MOPS) at a concentration of 10<sup>7</sup> cells/mL, and 100 &#x3bc;L of the inoculum was seeded into a 96-well microtiter plate. The biofilms formed on the surface of the wells were gently washed twice with phosphate-buffered saline (PBS) after 48&#xa0;h of incubation at 37&#xb0;C. The yeast cells were not washed immediately after the initial adhesion, and thus, the final time point (48&#xa0;h) reflects the total biomass that could not be initially adhered to. Crystal violet (CV) (Merck KGaA, Darmstadt, Germany) and water-soluble tetrazolium salts (WST-1) (TaKaRa, Shiga, Japan) were used in this study (<xref ref-type="bibr" rid="B32">Mukherjee et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B48">Weber et&#xa0;al., 2008</xref>). CV stained the whole biomass, including dead cells and polysaccharides, whereas WST was converted to a colored formazan in the presence of metabolic activity. To quantify the total biomass, washed biofilms were stained with 0.1% (w/v) CV solution for 1&#xa0;min. Each well was washed twice with PBS and dried for 30&#xa0;min. The bounded CV was eluted using 99.5% (v/v) ethanol. The burden of viable cells was estimated using WST-1 based on the reduction of tetrazolium salt. To each well, we added 100 &#x3bc;L of PBS and 10 &#x3bc;L of premixed WST-1, and the mixture was incubated at 37&#xb0;C for 3&#xa0;h under shade conditions. The absorbance (Abs) of CV and WST-1 was measured at 570 nm and 440 nm, respectively. Eight replicate wells were used for each strain, and experiments was repeated three times, independently.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Quantitative reverse transcription polymerase chain reaction</title>
<p>ISOGEN II (Nippon Gene, Co., Ltd., Tokyo, Japan) was used for total RNA extraction from the <italic>C. albicans</italic> HB-10 strain. The RNA concentrations were measured using a Qubit<sup>&#xae;</sup> RNA Assay Kit (Promega, WI, USA). To prepare complementary DNA, the PrimeScript&#x2122; RT reagent kit (TaKaRa, Shiga, Japan) was used in accordance with the manufacturer&#x2019;s instructions. Moreover, qRT-PCR analysis was performed using TB Green<sup>&#xae;</sup> Premix Ex Taq&#x2122; II (Tli RNaseH Plus) (TaKaRa, Shiga, Japan) in accordance with the manufacturer&#x2019;s protocol. Briefly, PCR was performed in a reaction mixture of TB Green Premix Ex Taq II (2 &#xd7;) 12.5 &#xb5;L, PCR forward primer 1 &#xb5;L, PCR reverse primer 1 &#xb5;L, and RNase free dH<sub>2</sub>O 8.5 &#xb5;L added to 2 &#xb5;L of each reverse transcription reaction solution. Primers used in this study are listed in <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;2</bold></xref>. The amplification conditions were as follows: 40 cycles under heat treatment at 95&#xb0;C for 30 s, heat denaturation at 95&#xb0;C for 5 s, and annealing at 55&#xb0;C for 30 s, which is the optimum temperature for the primer. Melting curves were used to verify the quality of qRT-PCR, and the fold expression was calculated using the delta-delta Ct method.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Supernatants produced by <italic>Lactobacillus</italic>
</title>
<p>Cell-free culture supernatants were extracted from <italic>Lactobacillus</italic> species. A single strain each was inoculated in de Man, Rogosa, and Sharpe (MRS) broth (Merck KGaA, Darmstadt, Germany) and incubated at 37&#xb0;C for 72-h under anaerobic conditions (10% H<sub>2</sub>, 10% CO<sub>2</sub>, and 80% N<sub>2</sub>) in an anaerobic chamber. Growth at the sampling point (72-h) was determined by measuring the optical density (OD) at 600 nm using a microplate reader (SH-9000Lab, HITACHI). The culture medium was then centrifuged at 3,500 &#xd7;<italic>g</italic> for 10&#xa0;min and filtered through a 0.22-&#x3bc;m membrane filter (Sarutorius AG, Gettingen, Germany). Each collected culture supernatant was stored at &#x2212;80&#xb0;C until use.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>High-performance liquid chromatography analysis of culture supernatants</title>
<p>HPLC (SHIMADZU, Kyoto, Japan) equipped with a conductivity detector was used to measure levels of lactate and short-chain fatty acids, such as acetate, propionate, and butyrate, in culture supernatants, as previously described (<xref ref-type="bibr" rid="B17">Hagihara et&#xa0;al., 2021</xref>). Briefly, the mobile phase required 5 mM p-toluenesulfonic acid (KANTO Chemical, Tokyo, Japan). The reaction buffer was made of 5 mM p-toluenesulfonic acid, 100 &#x3bc;M ethylenediaminetetraacetic acid (KANTO Chemical, Tokyo, Japan), and 20 mM bis (2-hydroxyethyl) aminotris (hydroxymethyl) methane (Tokyo Chemical Industry, Tokyo, Japan). The flow rate, oven temperature, and detector cell temperature were set at 0.8 mL/min, 40&#xb0;C, and 48&#xb0;C, respectively. The samples contained in 1.0 mL disposable vials (SHIMADZU Co., Kyoto, Japan) were held at 4&#xb0;C in a sample cooler (SHIMADZU, Kyoto, Japan), and 10 &#x3bc;L was applied to tandemly arranged two columns (SHIMADZU, Kyoto, Japan) to measure lactate levels. The calibration curve solution adjusted with lithium DL-lactate (FUJIFILM Wako Pure Chemical, Co., Ltd., Osaka, Japan) was dissolved in deionized water. The quantification analyses for HPLC were performed using LabSolutions version 5.90 (SHIMADZU Co., Kyoto, Japan), and the peak area was used as the signal intensity.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Detection of hydrogen peroxide in culture supernatants</title>
<p>Hydrogen peroxide production was estimated using a hydrogen peroxide assay kit (ab102500, Abcam, MA, USA) according to the manufacturer&#x2019;s instructions. The stored culture supernatant was neutralized to pH 7.0, and 100 &#x3bc;L of the adjusted supernatants were reacted for 10&#xa0;min in the presence of horseradish peroxidase. Duplicate wells were measured for each sample with absorbance at 595 nm, and experiments were repeated three times, independently.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Detection of pH in culture supernatants</title>
<p>The pH of cell-free culture supernatants and buffered RPMI 1640 medium, supplemented with culture supernatant, were measured promptly using a glass electrode-style hydrogen-ion concentration meter (Laqua, Horiba, Ltd., Japan). MRS (8%) was added to RPMI instead of <italic>Lactobacillus</italic> supernatant to achieve final concentrations of lactate and hydrogen peroxide standard of 4&#x2013;64 mM and 4 nM&#x2013;64 nM, respectively.</p>
</sec>
<sec id="s2_8">
<label>2.8</label>
<title>Measurement of minimum inhibitory concentration</title>
<p><italic>C. albicans</italic> sHB-10 were cultured for 24&#xa0;h in YPD agar at 30&#xb0;C under aerobic conditions. A single colony was inoculated into the YPD broth medium and incubated overnight for 16&#xa0;h at 30&#xb0;C, accompanied with shaking at 160 rpm under aerobic conditions. The cells were centrifuged at 3,500 &#xd7;g for 10&#xa0;min and re-suspended in RPMI 1640 medium at a concentration of 10<sup>6</sup> cells/mL. Lactate and hydrogen peroxide were added to the RPMI broth with 8% MRS and adjusted to a concentration ranging from 0.5 to 1024 mM and 0.5 nM to 1024 mM, respectively. After 24 hours of incubation at 37&#xb0;C, the turbidity of all well broth was visually observed, and the lowest concentration of lactate or hydrogen peroxide that suppressed the increased growth was determined as the MIC.</p>
</sec>
<sec id="s2_9">
<label>2.9</label>
<title>Effect of <italic>Lactobacillus</italic> culture supernatants on preformed <italic>C. albicans</italic> biofilm</title>
<p>The efficacy of the anti-biofilm activities of lactobacilli was determined by adding the culture supernatant of <italic>Lactobacillus</italic> to the preformed biofilm. <italic>C. albicans</italic> HB-10, which formed a mature biofilm in the assay described above, was selected and used for subsequent inhibition assays. A mature biofilm of <italic>C. albicans</italic> HB-10 was formed in a 96-well microtiter plate after 24&#xa0;h of incubation under the same conditions as the biofilm formation and viability assay. The planktonic cells were aspirated from each well and washed twice with PBS. Cell-free supernatant extracted from a single <italic>Lactobacillus</italic> strain was added to each well at a final concentration of 8% (v/v) and incubated for 24&#xa0;h. Culture supernatants were aspirated from each well and washed twice with PBS. Biofilm formation was quantified using CV and WST-1, as described above. The metabolic activity of the residual biofilm after the exposure of the <italic>Lactobacillus</italic> culture supernatant was quantified using WST-1 as described above. Eight replicate wells were used for each strains, and experiments was repeated three times, independently.</p>
</sec>
<sec id="s2_10">
<label>2.10</label>
<title>Effect of <italic>Lactobacillus</italic> culture supernatants on <italic>C. albicans</italic> hyphal formation</title>
<p>According to the hyphal formation method in the RPMI broth described previously (<xref ref-type="bibr" rid="B47">Wang et&#xa0;al., 2017</xref>), we estimated the effect of hyphal formation inhibition of <italic>C. albicans</italic> yeast-to-hyphal transition in the presence of <italic>Lactobacillus</italic> culture supernatants. <italic>Lactobacilli</italic> with strong inhibition of biofilm formation and those with low inhibition were selected. <italic>C. albicans</italic> HB-10 cells from overnight culture were washed with PBS and re-suspended at approximately 10<sup>6</sup> CFU/mL in RPMI 1640 medium buffered with MOPS. The yeast cell suspensions were then incubated with or without <italic>Lactobacillus</italic> culture supernatant at 37&#xb0;C for 3&#xa0;h. Quantification of the inhibitory effect of <italic>Lactobacillus</italic> on hyphal formation was performed using a light microscope (AxioCam MRc5; Carl Zeiss, Jena, Germany). The percentage of hyphal formation was calculated by obtaining the ratio of total number of <italic>C. albicans</italic> cells with hyphae to the total number of <italic>C. albicans</italic> cells counted. The number of yeast and hyphae (total cells) was counted using a hemocytometer (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Table&#xa0;3</bold></xref>).</p>
</sec>
<sec id="s2_11">
<label>2.11</label>
<title>Adhesion assay of <italic>C. albicans</italic> and <italic>Lactobacilli</italic>
</title>
<p>Human cervical cancer HeLa cells (RCB0007; Riken BRC Cell Bank, similar to ATCC CCL2) were grown in Dulbecco&#x2019;s modified Eagle&#x2019;s medium (DMEM; Thermo Fisher Scientific, MA, USA) supplemented with 10% (v/v) fetal bovine serum (Thermo Fisher Scientific, MA, USA) and 1% (v/v) penicillin and streptomycin (FUJIFULM Wako Pure Chemical, Co., Ltd., Osaka, Japan) at 37&#xb0;C under 5% CO<sub>2</sub> and humidity. HeLa cells were seeded into a 12-well plate (AGC Techno Glass Co., Ltd., Shizuoka, Japan) at approximately 1.0&#xd7;10<sup>5</sup> cells per well and grown to confluence. After 90% confluency, each well was washed twice with PBS. <italic>C. albicans</italic> HB-10 and lactobacilli were grown under the conditions described above. Briefly, a single colony of <italic>C. albicans</italic> HB-10 and lactobacilli was inoculated into YPD and MRS broth, respectively. After 48&#xa0;h of incubation, both <italic>C. albicans</italic> HB-10 and lactobacilli cells were collected using centrifugation at 3,500 &#xd7;<italic>g</italic> for 10&#xa0;min and re-suspended in DMEM. The suspension of <italic>C. albicans</italic> HB-10 and lactobacilli contained approximately 1.0&#xd7;10<sup>7</sup> CFU/mL. To the HeLa cell culture well, 100 &#x3bc;L of 10-fold serial dilutions of lactobacilli suspensions was added and incubated at 37&#xb0;C for 1&#xa0;h under 5% CO<sub>2</sub>. Subsequently, 100 &#x3bc;L of 10-fold serial dilutions of <italic>C. albicans</italic> HB-10 suspensions was added to each well and incubated for 1&#xa0;h under the same conditions to allow <italic>C. albicans</italic> HB-10 to adhere to cells. After incubation, each well was washed twice with PBS to remove non-adherent <italic>C. albicans</italic> cells and then treated with 0.05% trypsin-EDTA (Nacalai Tesque, Inc., Kyoto, Japan). The inhibitory rate of adhesion was calculated as the number of <italic>C. albicans</italic> cells that adhered to HeLa cells with <italic>Lactobacillus</italic> pre-treatment, per the number of <italic>C. albicans</italic> cells that adhered to HeLa cells in the absence of lactobacilli.</p>
</sec>
<sec id="s2_12">
<label>2.12</label>
<title>Statistical analysis</title>
<p>Statistical analyses were performed using R and RStudio (versions 4.0.3 and 1.4.1106, respectively). Mann&#x2013;Whitney U-test was used to determine significant differences between DMEM control and different lactobacilli. One-way analysis of variance was used to compare multiple groups. Statistical significance was set at <italic>p</italic> values &lt;0.05. Correlations between growth and metabolites (lactate and hydrogen peroxide) were determined using Spearman&#x2019;s rank correlation coefficient.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Biofilm formation abilities of <italic>C. albicans</italic>
</title>
<p>Biofilm formation by <italic>C. albicans</italic> clinical isolates was assessed using the WST-1 formazan dye (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1A</bold></xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Clinical isolates of <italic>Candida albicans</italic> with different abilities to form biofilms. CV, crystal violet; WST, water-soluble tetrazolium salts. <bold>(A)</bold> The biofilm formation of 45 clinical isolates of <italic>C albicans</italic> were used to measure WST-1 and are exhibited by the box whisker plots. Box plot shows the median (horizontal thick blank line), mean (cross), and first and third quartiles (box). <bold>(B)</bold> Biofilm formation by different <italic>C albicans</italic> strains was estimated using both WST-1 reduction and CV staining. *<italic>p</italic> &lt; 0.05 by U-test compared with WST-1 absorbance of <italic>C albicans</italic> HB-10. <sup>&#x2020;</sup><italic>p</italic> &lt; 0.05 by U-test compared with crystal violet (CV) absorbance of <italic>C albicans</italic> HB-10. <bold>(C)</bold> Relative quantitation of genes associated with adherence repression (<italic>YWP1</italic>), or hyphal formation (<italic>HWP1</italic> and <italic>ECE1</italic>) normalized to the &#x3b2;-actin gene. The <italic>C albicans</italic> HB-10 strain was used as the reference to depict the difference among the four <italic>C albicans</italic> clinical isolates. Bars represent the standard deviation from the mean values. *<italic>p</italic> &lt; 0.05 and **<italic>p</italic> &lt; 0.01 by U-test.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1113401-g001.tif"/>
</fig>
<p>Among these 45 strains, representative strains that reproduced well and showed significant differences in the CV assay were selected as high and low biofilm-producing strains and renamed as <italic>C. albicans</italic> HB-1 and HB-10 and <italic>C. albicans</italic> LB-9 and LB-22, respectively (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1B</bold></xref>). The expression levels of the three genes, <italic>ECE1</italic>, <italic>HWP1</italic>, and <italic>YWP1</italic>, which regulate different stages of biofilm formation in <italic>C. albicans</italic>, were determined using qRT-PCR (<xref ref-type="fig" rid="f1"><bold>Figure&#xa0;1C</bold></xref>).</p>
<p>Four <italic>C. albicans</italic> strains with gene expression of <italic>HWP1</italic>, <italic>ECE1</italic>, <italic>and YWP1</italic> exhibited bar plots normalized by <italic>C. albicans</italic> HB-10 gene expression levels. These gene expression levels were calculated according to <italic>ACT1</italic> gene expression levels. Similar to the phenotypic biofilm-forming analysis, the relative gene expression levels of <italic>ECE1</italic> and <italic>HWP1</italic> in the HB-10 strain were significantly higher than those in the LB-9 (10.53-fold and 3.21-fold, respectively) and LB-22 strains (31.21-fold and 8.72-fold, respectively) (<italic>p</italic> &lt; 0.05). Interestingly, the HB-1 strain, which was a high biofilm producer and did not show such a large difference in biofilm-forming ability, had significantly lower expression levels of these genes than the HB-10 strain. In contrast, <italic>YWP1</italic>, which suppressed initial adhesion, was the lowest in the HB-10 strain.</p>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Characterization of culture supernatant</title>
<p>Vaginal lactobacilli produce various metabolites that exhibit antifungal activity. Cell-free culture supernatants extracted from 27 strains of <italic>Lactobacillus</italic> belonging to five species after 48-h incubation were characterized (<xref ref-type="fig" rid="f2"><bold>Figure&#xa0;2</bold></xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Lactate and hydrogen peroxide production by 27 <italic>Lactobacillus</italic> clinical isolates. Twenty-seven <italic>Lactobacillus</italic> clinical isolates were cultured in de Man, Rogosa, and Sharpe (MRS) broth for 72&#xa0;h, and cell-free culture supernatants were collected. Lactate level was measured quantitatively by high-performance liquid chromatography (HPLC), and hydrogen peroxide was measured quantitatively using a hydrogen peroxide assay kit. Data are represented by the mean across the three replicates.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1113401-g002.tif"/>
</fig>
<p>The lactate and hydrogen peroxide production of lactobacilli used in this study ranged from 42.1 to 201.7 mM and 38.7 to 170.8 nM, respectively. There was no correlation between lactate production and hydrogen peroxide production (<italic>r</italic> = 0.426; <italic>p</italic> = 0.217). In contrast, OD corresponding to the growth of <italic>Lactobacilli</italic> and lactate levels at the 72-h sampling point showed moderately positive correlations (<italic>r</italic> = 0.667; <italic>p</italic> &lt; 0.001), while OD and hydrogen peroxide levels showed no correlation (<italic>r</italic> = 0.265; <italic>p</italic> = 0.181) (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;2</bold></xref>). In <italic>L. jensenii</italic>, the average hydrogen peroxide production was the highest compared to other species (mean 146.0 nM), although lactate production was not as high (ranging from 81.3 to 126.5 mM).</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Effect of <italic>Lactobacillus</italic> culture supernatant on preformed biofilm</title>
<p>In a typical experiment using 96 well plates, biofilm formation takes 24&#xa0;h to reach confluency. We investigated the effects of <italic>Lactobacillus</italic> culture supernatants on preformed biofilms (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3</bold></xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Metabolic activity of the biofilm of <italic>C. albicans</italic> HB-10 treated with culture supernatants of 27 different <italic>Lactobacillus</italic> clinical isolates. The x-axis indicates the strain number and lactic acid concentration (mM). The burden of viable cells of preformed biofilm treated after culture supernatants of 27 different <italic>Lactobacillus</italic> clinical isolates was measured using the WST-1 reduction reaction. MRS broth was used as the control. WST, water-soluble tetrazolium salts; MRS, de Man, Rogosa, and Sharpe. Box plot shows the median (horizontal thick blank line), mean (cross), and first and third quartiles (box). Bars represent the standard deviation from the mean values. *<italic>p</italic> &lt; 0.05 and **<italic>p</italic> &lt; 0.01 by U-test.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1113401-g003.tif"/>
</fig>
<p>The addition of <italic>Lactobacillus</italic> culture supernatant resulted in 24.3%-91.8% relative WST-1 readings compared with those of non-added control. The culture supernatants of <italic>L. crispatus</italic>, <italic>L. gasseri</italic>, <italic>L. jensenii</italic>, and <italic>L. vaginalis</italic> with average relative WST-1 readings were approximately 52.5%, 43.1%, 57.2%, and 58.9%, respectively. The effect of different lactobacilli species on preformed biofilms of <italic>C. albicans</italic> HB-10 did not differ significantly. A moderate negative correlation was found between <italic>Lactobacillus</italic> lactate production and WST-1 readings (<italic>r</italic> = &#x2212;0.625; <italic>p &lt;</italic>0.001), but no correlation was observed between hydrogen peroxide production and WST-1 readings (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;3</bold></xref>).</p>
<p>We added several concentrations of the standards to the biofilm to reproduce lactate and hydrogen peroxide as metabolites in the culture supernatant (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;4</bold></xref>). The results showed that lactate concentrations had lower WST values than controls at all concentrations except 4 mM and a concentration-dependent effect on WST values (<italic>r</italic> = -0.930; <italic>p</italic> = 0.001). In contrast, hydrogen peroxide had no concentration-dependent effect on the preformed biofilm, with WST values not significantly different from the control at all concentrations. Lactate and hydrogen peroxide further showed no additive or synergistic effects on the preformed biofilms. A strong effect on the preformed biofilm was observed when the culture supernatant of the <italic>L. crispatus</italic> 35-1 strain was added (final concentration 14.1 mM), which was consistent with the WST-1 values for the biofilm when the 16 mM lactate standard was added (<xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3</bold></xref> and <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;4</bold></xref>).</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Effect of <italic>Lactobacillus</italic> culture supernatant on the growth of planktonic cultures</title>
<p>The inhibitory effect of <italic>Lactobacillus</italic> spp. on <italic>C. albicans</italic> yeast cell growth was also evaluated. Significant growth inhibition was shown in 4/27 (14.8%) of the strains with the addition of culture supernatant of each <italic>Lactobacillus</italic> as follows: <italic>L. crispatus</italic> strain 23-1 and 20-2, <italic>L. gasseri</italic> strain 31-1 and <italic>L. rhamnosus</italic> strain 14-1. Interestingly, three of these strains showed lactate and hydrogen peroxide production above 165 mM and 120 nM, respectively (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;7</bold></xref>). The MICs for lactate and hydrogen peroxide standard for <italic>C. albicans</italic> HB-10 samples were 512 mM and 20 mM, respectively.</p>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Effect of <italic>Lactobacillus</italic> culture supernatant on the hyphal formation</title>
<p>The effect on the rate of hyphal formation was compared for <italic>Lactobacillus</italic> culture supernatants that exhibited significant differences in their WST values to the preformed biofilm and for those that did not (<xref ref-type="fig" rid="f4"><bold>Figure&#xa0;4</bold></xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Hyphal formation rate of <italic>C. albicans</italic> HB-10 strain treated with <italic>Lactobacillus</italic> culture supernatants, lactate, or hydrogen peroxide. The x-axis indicates the strain number and lactic acid concentration (mM) or lactate concentration or hydrogen peroxide concentration. Relative hyphal formation in <italic>C. albicans</italic> HB-10 treated with culture supernatants of 10 different <italic>Lactobacillus</italic> clinical isolates, lactate, or hydrogen peroxide. Bars represent the standard deviation from the mean values. MRS broth was used as the control. MRS, de Man, Rogosa, and Sharpe. *<italic>p</italic> &lt; 0.05 by U-test.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1113401-g004.tif"/>
</fig>
<p>Yeast, hyphae, and pseudohyphae were identified under a microscope (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;8</bold></xref>). The addition of MRS medium control resulted in 54.95 &#xb1; 9.61% of the hyphae, and pseudohyphae were identified after 3&#xa0;h of incubation. Compared to MRS control alone, lactate standards showed a concentration-dependent decrease in hyphal formation at 16 to 64 mM (<italic>p</italic>&lt;0.05), while only 64 nM of hydrogen peroxide showed a significant difference. The percentage of hyphal formation by <italic>Lactobacillus</italic> culture supernatants ranged from 18.11 to 54.77%. In terms of the percentage of a hyphal formation relative to untreated MRS, significant decreases were observed with the addition of culture supernatant in <italic>L. crispatus</italic> strain 35-1 (32.97 &#xb1; 13.29%) and 53-1 (39.10 &#xb1; 7.40%), <italic>L. gasseri</italic> strain 45-3-1 (56.99 &#xb1; 6.90%) and 32-2 (70.75 &#xb1; 4.15%), and <italic>L. vaginalis</italic> strain 41-1 (70.60 &#xb1; 8.12%). All of these showed final lactate concentrations &gt;50 mM. In contrast, although there were no differences in lactate and hydrogen peroxide metabolite profiles between <italic>L. gasseri</italic> strains 45-3-1 and 45-3-2, only strain 45-3-1 showed significantly lower hyphal formation than the MRS control.</p>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>Effect of <italic>Lactobacillus</italic> bacterial cell on the initial adhesion</title>
<p>The inhibition of <italic>C. albicans</italic> yeast adhesion to human epithelial cells by <italic>Lactobacillus</italic> bacterial cells was assessed (<xref ref-type="fig" rid="f5"><bold>Figure&#xa0;5</bold></xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Adhesion of <italic>C. albicans</italic> HB-10 strain to HeLa cells according to the presence or absence of lactobacilli. Relative adherence of the <italic>C. albicans</italic> HB-10 strain to HeLa cells pretreated with DMEM or different lactobacilli. Bars represent the standard deviation from the mean values. *<italic>p</italic> &lt; 0.05 by U-test. DMEM, Dulbecco&#x2019;s modified Eagle&#x2019;s medium. n.s., not significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1113401-g005.tif"/>
</fig>
<p><italic>L. crispatus</italic> strain 35-1 showed a more efficient inhibition of <italic>C. albicans</italic> HB-10 (adhesion rate: 68.29 &#xb1; 6.90%). In contrast, <italic>L. crispatus</italic> strain 3-1-2 showed no statistically significant difference (adhesion rate: 93.90 &#xb1; 25.87%). Interestingly, <italic>L. gasseri</italic> strain 45-3-1, which showed inhibition of hyphal formation, also showed a significant reduction in <italic>C. albicans</italic> HB-10 adhesion (80.95 &#xb1; 3.17%), whereas strain 45-3-2 showed no inhibitory effect on initial adhesion (89.68 &#xb1; 2.38%).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>This study presents the steps of <italic>C. albicans</italic> biofilm formation that are affected by clinical isolates of lactobacilli. The analysis focuses on lactate and hydrogen peroxide among the metabolites (culture supernatants), and adhesion analyses were performed using viable bacteria.</p>
<p>The virulence of <italic>C. albicans</italic> in VVC is complexly related to multiple factors such as adhesion to cell surfaces and inert surfaces, cell damage by hydrolases and candidalysin, and subsequent active hyphal invasion, biofilm formation, and phenotypic switching (<xref ref-type="bibr" rid="B3">Berman and Sudbery, 2002</xref>; <xref ref-type="bibr" rid="B31">Moyes et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B9">Czechowicz et&#xa0;al., 2022</xref>). <italic>C. albicans</italic> yeast cells express adhesin and adhere to the host cell surface. HWP1 and a group of eight glycosylated proteins (<italic>ALS1-ALS7</italic> and <italic>ALS9</italic>) associated with the ALS gene are important adhesins (<xref ref-type="bibr" rid="B38">Rodr&#xed;guez-Cerdeira et&#xa0;al., 2020</xref>). HWP1 is important as a component of the hyphal cell wall and may stabilize biofilms by adhering to yeast cells and hyphae in biofilms, making them highly pathogenic to the host (<xref ref-type="bibr" rid="B53">Zhu and Filler, 2010</xref>; <xref ref-type="bibr" rid="B46">Talapko et&#xa0;al., 2021</xref>). In addition to adhesion to cell surfaces, HWP1 is involved in adhesion to inert surfaces (<xref ref-type="bibr" rid="B33">Nobile et&#xa0;al., 2006</xref>). <italic>C. albicans</italic> yeast cells are transferred to hyphae by various environmental factors such as pH, CO<sub>2</sub> concentration, temperature, and N-acetylglucosamine (<xref ref-type="bibr" rid="B45">Sudbery, 2011</xref>). <italic>C. albicans</italic> invades cells from the cell surface in two ways: passive invasion by endocytosis and active invasion by disrupting the cell surface with hydrolases and candidalysin (<xref ref-type="bibr" rid="B31">Moyes et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B29">Maza et&#xa0;al., 2017</xref>). In particular, candidalysin, encoded by the ECE1 gene, directly disrupts epithelial cells by acting as a cytolytic peptide toxin (<xref ref-type="bibr" rid="B31">Moyes et&#xa0;al., 2016</xref>). <italic>C. albicans s</italic>ecretes candidalysin into the hyphal entry pocket, effectively destroying the tissue and establishing a mucosal infection with <italic>C. albicans</italic> (<xref ref-type="bibr" rid="B30">Mogavero et&#xa0;al., 2021</xref>). YWP1 inhibits adhesion of <italic>C. albicans</italic> yeast cells to the cell surface. Furthermore, YWP1 may express mannoproteins on the outer layer of the yeast cell wall, which may cover the epitope &#x3b2;-1,3-glucan and allow it to escape the immune system (<xref ref-type="bibr" rid="B14">Granger, 2012</xref>; <xref ref-type="bibr" rid="B15">Granger, 2018</xref>).</p>
<p>In this study, <italic>C. albicans</italic> biofilms are formed on inert surfaces (microtiter plates). For this reason, we evaluated the expression level of the HWP1 gene, which is important for inert surface attachment and is also associated with hyphal formation (<xref ref-type="bibr" rid="B33">Nobile et&#xa0;al., 2006</xref>). Candidalysin is encoded by <italic>ECE1</italic> and is important for active invasion of <italic>C. albicans</italic> by disrupting the host cell surface (<xref ref-type="bibr" rid="B31">Moyes et&#xa0;al., 2016</xref>). Since <italic>ECE1</italic> is an important gene for the invasion of C. albicans hyphae into HeLa cells, which are biotic surfaces, we evaluated the gene expression of <italic>ECE1</italic>. HB-10, which formed the highest amount of biofilms on inert surfaces (microtiter plates), was found to express high levels of HWP1. In contrast, HB-1 formed high biofilms, although the gene expression levels of <italic>HWP1</italic> and <italic>ECE1</italic> were low, indicating a dissociation between phenotype and gene expression. This may be because hyphal formation and invasion of epithelial cell, which is important for biofilm formation, are composed of multiple signal transduction pathways (<xref ref-type="bibr" rid="B45">Sudbery, 2011</xref>). For the <italic>C. albicans</italic> HB-10 biofilm, <italic>C. albicans</italic> biofilm formations were initiated using a 96-well plate in this study.</p>
<p>A strong effect on the preformed biofilm was observed when the culture supernatant of the <italic>L. crispatus</italic> 35-1 strain was added (final concentration, 14.1 mM), which is consistent with the WST-1 values for the biofilm when the 16 mM lactate standard was added. A healthy human vaginal environment is maintained at a low pH. In this acidic pH environment, <italic>C. albicans</italic> is less likely to undergo a morphological yeast-fungus transition (<xref ref-type="bibr" rid="B10">Davis et&#xa0;al., 2000</xref>). The pH of the buffered RPMI 1640 medium used in this study, supplemented with culture supernatant of the <italic>L. crispatus</italic> 35-1 strain (final concentration 14.1 mM) and 16 mM lactate standard, had similar levels (at a pH range of 4.3 to 4.6) This suggests that direct pH reduction due to lactate might be responsible for the anti-<italic>C. albicans</italic> activities. This is confirmed by the fact that the inhibition of biofilm and hyphal formation disappears when the 4&#x2013;64 mM Lactate standard is neutralized using NaOH (<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figures&#xa0;5</bold></xref>, <xref ref-type="supplementary-material" rid="SM1"><bold>6</bold></xref>). The MIC values for planktonic yeast were 512 mM for lactate and 20 mM for hydrogen peroxide. For the preformed biofilm in <xref ref-type="fig" rid="f3"><bold>Figure&#xa0;3</bold></xref>, the concentration range for 8% <italic>Lactobacillus</italic> supernatant addition was 3.4 - 16.1 mM for lactate and 3.1 - 13.7 nM for hydrogen peroxide. In <xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Figure&#xa0;6</bold></xref>, regarding lactate and hydrogen peroxide standard samples, lactate inhibited preformed biofilms at 16 mM-64 mM; however, hydrogen peroxide did not inhibit at all in any concentration. Therefore, at sub-MIC concentrations, lactate (both supernatant and standard samples) may show fungistatic activities, whereas hydrogen peroxide may not. Fluconazole, a therapeutic agent for VVC, shows fungistatic activities against <italic>C. albicans</italic>, and increased susceptibility to fluconazole has been reported in biofilms in the presence of lactate (<xref ref-type="bibr" rid="B2">Alves et&#xa0;al., 2017</xref>). This could lead to the development of a new <italic>C. albicans</italic> treatment by combining <italic>Lactobacillus</italic> and fluconazole.</p>
<p>Hyphal formation and growth are associated with <italic>C. albicans</italic> virulence (<xref ref-type="bibr" rid="B19">Jang et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B39">Roselletti et&#xa0;al., 2019</xref>). HB-10 used in this study expresses the <italic>ECE1</italic> gene; Ece1p, a protease encoded by <italic>ECE1</italic>, causes inflammation in epithelial cells and allows <italic>C. albicans</italic> hyphae to adhere to and invade the cell epithelium (<xref ref-type="bibr" rid="B31">Moyes et&#xa0;al., 2016</xref>). To inhibit biofilm formation, it is important to prevent <italic>C. albicans</italic> adhesion to the epithelial cells. In the present study, lactate inhibited hyphal formation in a concentration-dependent manner. Despite the similar metabolic profiles of lactate and hydrogen peroxide in <italic>L. gasseri</italic> strains 45-3-1 and 45-3-2, only strain 45-3-1 significantly inhibited hyphal formation. Similarly, among the <italic>L. gasseri</italic> strains 45-3-1 and 45-3-2, only strain 45-3-1 significantly inhibited <italic>C. albicans</italic> adhesion to epithelial cells. This suggests that metabolites other than lactate and hydrogen peroxide inhibit hyphal formation. Indeed, recent studies have suggested that small molecules produced by <italic>Lactobacillus</italic> may inhibit <italic>C. albicans</italic> biofilm formation and growth as antimicrobial compounds (<xref ref-type="bibr" rid="B23">Lee et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B25">MacAlpine et&#xa0;al., 2021</xref>). <italic>L. crispatus</italic> strain 35-1 and <italic>L. gasseri</italic> strain 45-3-1 showed a significant reduction in <italic>C. albicans</italic> HB-10 adhesion (adhesion rates: 68.29 &#xb1; 6.90% and 80.95 &#xb1; 3.17%, respectively) to HeLa cells. Thus, different <italic>Lactobacillus</italic> strains showed different rates of inhibition of <italic>C. albicans</italic> HB-10 adhesion to HeLa cells. In the experimental setup of this study, <italic>Lactobacillus</italic> first adhered to HeLa cells before <italic>C. albicans</italic> was added. Although an accurate count of lactobacilli, which adhere to HeLa cells could not be obtained in this study, our findings reveal the <italic>Lactobacillus</italic> strain with high attachment ability to HeLa cells, which may preferentially adhere to a limited number of epithelial cell surfaces, indicating that <italic>C. albicans</italic> was physically unable to adhere to these cells. In this study, <italic>L. crispatus</italic> 35-1 and <italic>L. gasseri</italic> 45-3-1 strains inhibited <italic>C. albicans</italic> adhesion but failed to reduce it to less than 50%. Thus, it should be noted that in terms of multiplicity of infection, the inhibitory effect of <italic>Lactobacillus</italic> used in this study on <italic>C. albicans</italic>&#x2019;s epithelial cell attachment is not so strong.</p>
<p>Several studies using clinical isolates and deposited strains in biofilm formation inhibition testing have been reported. Culture supernatant of a clinically isolated strain, <italic>Lactobacillus crispatus</italic> BC1-BC8, inhibited biofilm formation (Itapary Dos <xref ref-type="bibr" rid="B18">Santos et&#xa0;al., 2019</xref>). Compared to no cell-free culture supernatants, culture supernatants of deposited strains, <italic>Lactobacillus fermentum</italic> ATCC 23271 and <italic>L. rhamnosus</italic> ATCC 9595, inhibited biofilm formation by more than 40% in the CV and 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide assays (Itapary Dos <xref ref-type="bibr" rid="B18">Santos et&#xa0;al., 2019</xref>). On the other hand, the addition of cell-free culture supernatants of <italic>Lactobacillus</italic> iners ATCC 55195 significantly increased hyphal and biofilm formation of <italic>C. albicans</italic> compared to the control (<xref ref-type="bibr" rid="B41">Sabbatini et&#xa0;al., 2021</xref>). Matsuda et&#xa0;al. reported no inhibitory effect when 7.5% <italic>L. crispatus</italic> JCM 1185 and <italic>L. gasseri</italic> JCM 1131 culture supernatants were added to the <italic>C. albicans</italic> preformed biofilm (<xref ref-type="bibr" rid="B27">Matsuda et al., 2018</xref>). In our study, culture supernatants of 8% <italic>L. crispatus</italic> JCM 1185 and <italic>L. gasseri</italic> JCM 1131 exhibited no inhibitory effect on the biofilm (Residual biofilm 78.2% and 66.7% compared with no cell-free culture supernatants control), suggesting that the reproducibility of previous reports has been achieved. However, <italic>L. crispatus</italic> 35 -1 and <italic>L. gasseri</italic> 45 -3 -1 in this study significantly inhibited the pre-formed biofilm. The hyphae formation rate of <italic>L. crispatus</italic> JCM 1185 was 28.0%, which was not significantly different from that of clinical isolates. In contrast, that of <italic>L. gasseri</italic> JCM 1131 was 6.6%, which is interesting because it has a higher inhibitory effect than clinical isolates.</p>
<p>A worrisome trend is that VVC caused by non-<italic>albicans Candida</italic> species (NAC), <italic>C. tropicalis, C. krusei</italic>, and <italic>C. glabrata</italic>, has been increasing (<xref ref-type="bibr" rid="B54">Zhou et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B36">Ravel et&#xa0;al., 2011</xref>). In particular, <italic>C. tropicalis</italic> is frequently isolated in Asia and is known to have high hyphal budding ability and form strong biofilms that are resistant to treatment (<xref ref-type="bibr" rid="B4">Bizerra et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B36">Ravel et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B22">Kawai et&#xa0;al., 2017</xref>). Although <italic>C. tropicalis</italic> has good <italic>in vitro</italic> drug susceptibility to azoles, candins, and polyenes, the poor clinical prognosis may be related to biofilm formation (<xref ref-type="bibr" rid="B51">Yamagishi et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B42">Sakagami et&#xa0;al., 2019</xref>). Visualization of biofilm formation has shown that candin- and polyene-based drugs are suitable for biofilm-forming NAC (<xref ref-type="bibr" rid="B21">Kawai et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B22">Kawai et&#xa0;al., 2017</xref>). In the actual human vaginal environment, glycogen is digested by &#x3b1;-amylase to produce maltose, maltotriose, and maltotetraose (<xref ref-type="bibr" rid="B44">Spear et&#xa0;al., 2014</xref>). <italic>Lactobacilli</italic> are known to consume glycogen-breakdown products to produce lactate. However, <italic>in vitro</italic> experiments have not fully mimicked the vaginal environment with respect to nutrient sources for <italic>Lactobacillus</italic> development, which may have affected their growth and metabolite production (<xref ref-type="bibr" rid="B44">Spear et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B34">Nunn et&#xa0;al., 2020</xref>). Thus, classically defined bacterial aerobes and anaerobes form a community of microaerophilic environments in the mucosa lining the vaginal lumen. In this study, optimal growth environments for <italic>Lactobacillus</italic> and <italic>C. albicans</italic> were selected (anaerobic and aerobic conditions, respectively). However, it is difficult to reproduce the complex vaginal ecosystem under a single culture condition in an <italic>in vitro</italic> experimental system; thus, it is necessary to set <italic>Lactobacillus</italic> and <italic>C. albicans</italic> in aerobic, microaerobic, and anaerobic conditions to evaluate biofilms. The results of this study suggest that <italic>Lactobacillus</italic> metabolites other than lactate and hydrogen peroxide may also affect <italic>C. albicans</italic>, although they have not been evaluated in detail. In future, the effects of various metabolites produced by <italic>Lactobacillus</italic> on <italic>C. albicans</italic> need to be evaluated under conditions that are more similar to the human vaginal environment. In this study, the effects of lactate and hydrogen peroxide on <italic>C. albicans</italic> HB10 biofilm and hyphal formation are investigated using lactate and hydrogen peroxide standard samples. However, metabolites other than lactate and hydrogen peroxide are possibly involved in <italic>C. albicans</italic> biofilm formation. Therefore, it is necessary to consider the effects of the absence of lactate and hydrogen peroxide, while considering the effects of various metabolites using <italic>Lactobacillus</italic> strains that cannot synthesize lactate and hydrogen peroxide. This study has not been able to evaluate this issue. The effect of <italic>Lactobacillus</italic> supernatant on <italic>C. albicans</italic> biofilm formation and the change from yeast to hyphal form could be better understood by imaging evaluation using electron microscopy. However, due to equipment limitations, electron microscopic evaluation was not available for this study. In future studies, evaluation with images should also be considered.</p>
<p>In this study, quantitative evaluation of lactobacilli metabolite (lactate and hydrogen peroxide) concentrations revealed that the inhibitory effects of lactate and hydrogen peroxide on <italic>C. albicans</italic> might be acting through multiple stages, such as <italic>C. albicans</italic> growth, hyphal formation, biofilm development, and adhesion to epithelial cells. Therefore, combining antifungal drugs with lactobacilli as a live biotherapeutic product, with anti-biofilm development activity, may lead to the development of new treatment strategies. Future studies are required to evaluate how lactobacilli affect both <italic>C. albicans</italic> and NAC, to promote the global use of lactobacilli.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1"><bold>Supplementary Material</bold></xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>Conceptualization: TT and HaK. Methodology: HaK, KO, and TK. Software: SE. Validation: TT, AM, and HaK. Formal analysis: SE. Investigation: TT, SE, AM, and HaK. Resources: TT. Data curation: HaK. Writing-original draft preparation: TT, SE, AM, and HaK. Writing-review and editing: TT. Visualization: ES. Supervision: YukiY, MT, YukaY, HT, HM, and HiK. Project administration: TT. Funding acquisition: MT and HiK. All authors have read and agreed to the published version of the manuscript.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank Microskylab Inc. (Tokyo, Japan) for providing <italic>C. albicans</italic> samples.</p>
</ack>
<sec id="s7" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>HaK, SE, AM, KO, and MT are employees of Miyarisan Pharmaceutical Co., Ltd.; however, they have no conflicts of interest to declare regarding this study.</p>
<p>The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s8" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s9" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2023.1113401/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2023.1113401/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aarti</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Khusro</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Varghese</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Arasu</surname> <given-names>M. V.</given-names>
</name>
<name>
<surname>Agastian</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Al-Dhabi</surname> <given-names>N. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title><italic>In vitro</italic> investigation on probiotic, anti-<italic>candida</italic>, and antibiofilm properties of <italic>Lactobacillus pentosus</italic> strain LAP1</article-title>. <source>Arch. Oral. Biol.</source> <volume>89</volume>, <fpage>99</fpage>&#x2013;<lpage>106</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.ARCHORALBIO.2018.02.014</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alves</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Mota</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Silva</surname> <given-names>S.</given-names>
</name>
<name>
<surname>F Rodrigues</surname> <given-names>C.</given-names>
</name>
<name>
<surname>P Brown</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Henriques</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>The carboxylic acid transporters Jen1 and Jen2 affect the architecture and fluconazole susceptibility of <italic>Candida albicans</italic> biofilm in the presence of lactate</article-title>. <source>Biofouling</source> <volume>33</volume>, <fpage>943</fpage>&#x2013;<lpage>954</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/08927014.2017.1392514</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berman</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Sudbery</surname> <given-names>P. E.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Candida albicans: a molecular revolution built on lessons from budding yeast</article-title>. <source>Nat. Rev. Genet.</source> <volume>3</volume>, <fpage>918</fpage>&#x2013;<lpage>931</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrg948</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bizerra</surname> <given-names>F. C.</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>C. V.</given-names>
</name>
<name>
<surname>de Poersch</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Estivalet Svidzinski</surname> <given-names>T. I.</given-names>
</name>
<name>
<surname>Borsato Quesada</surname> <given-names>R. M.</given-names>
</name>
<name>
<surname>Goldenberg</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Characteristics of biofilm formation by <italic>Candida tropicalis</italic> and antifungal resistance</article-title>. <source>FEMS Yeast Res.</source> <volume>8</volume>, <fpage>442</fpage>&#x2013;<lpage>450</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/J.1567-1364.2007.00347.X</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bongomin</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Gago</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Oladele</surname> <given-names>R. O.</given-names>
</name>
<name>
<surname>Denning</surname> <given-names>D. W.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Global and multi-national prevalence of fungal diseases-estimate precision</article-title>. <source>J. Fungi (Basel)</source> <volume>3</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/JOF3040057</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chandra</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Mukherjee</surname> <given-names>P. K.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title><italic>Candida</italic> biofilms: development, architecture, and resistance</article-title>. <source>Microbiol. Spectr.</source> <volume>3</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/microbiolspec.MB-0020-2015</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chee</surname> <given-names>W. J. Y.</given-names>
</name>
<name>
<surname>Chew</surname> <given-names>S. Y.</given-names>
</name>
<name>
<surname>Than</surname> <given-names>L. T. L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Vaginal microbiota and the potential of <italic>Lactobacillus</italic> derivatives in maintaining vaginal health</article-title>. <source>Microb. Cell Fact</source> <volume>19</volume>, <fpage>203</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/S12934-020-01464-4</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooke</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Watson</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Deckx</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Pirotta</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>J.</given-names>
</name>
<name>
<surname>van Driel</surname> <given-names>M. L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Treatment for recurrent vulvovaginal candidiasis (thrush)</article-title>. <source>Cochrane Database Syst. Rev.</source> <volume>1</volume>, <elocation-id>CD009151</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/14651858.CD009151.pub2</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Czechowicz</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Nowicka</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Go&#x15b;ciniak</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Virulence factors of <italic>Candida</italic> spp. and host immune response important in the pathogenesis of vulvovaginal candidiasis</article-title>. <source>Int. J. Mol. Sci.</source> <volume>23</volume>, <elocation-id>5895</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms23115895</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>R. B.</given-names>
</name>
<name>
<surname>Mitchell</surname> <given-names>A. P.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>RIM101-dependent and-independent pathways govern pH responses in <italic>Candida albicans</italic>
</article-title>. <source>RIM Mol. Cell. Biol.</source> <volume>20</volume>, <fpage>971</fpage>&#x2013;<lpage>978</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/MCB.20.3.971-978.2000</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denning</surname> <given-names>D. W.</given-names>
</name>
<name>
<surname>Kneale</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Sobel</surname> <given-names>J. D.</given-names>
</name>
<name>
<surname>Rautemaa-Richardson</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Global burden of recurrent vulvovaginal candidiasis: a systematic review</article-title>. <source>Lancet Infect. Dis.</source> <volume>18</volume>, <fpage>e339</fpage>&#x2013;<lpage>e347</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1473-3099(18)30103-8</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Drgona</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Khachatryan</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Stephens</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Charbonneau</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Kantecki</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Haider</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of <italic>Aspergillus</italic> and <italic>Candida</italic> species</article-title>. <source>Eur. J. Clin. Microbiol. Infect. Dis.</source> <volume>33</volume>, <fpage>7</fpage>&#x2013;<lpage>21</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/S10096-013-1944-3</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fisher</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Alastruey-Izquierdo</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Berman</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Bicanic</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Bignell</surname> <given-names>E. M.</given-names>
</name>
<name>
<surname>Bowyer</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Tackling the emerging threat of antifungal resistance to human health</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>20</volume>, <fpage>557</fpage>&#x2013;<lpage>571</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/S41579-022-00720-1</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Granger</surname> <given-names>B. L.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Insight into the antiadhesive effect of yeast wall protein 1 of <italic>Candida albicans.</italic> eukaryot</article-title>. <source>Cell</source> <volume>11</volume>, <fpage>795</fpage>&#x2013;<lpage>805</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/EC.00026-12</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Granger</surname> <given-names>B. L.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Accessibility and contribution to glucan masking of natural and genetically tagged versions of yeast wall protein 1 of <italic>Candida albicans</italic>
</article-title>. <source>PloS One</source> <volume>13</volume>, <elocation-id>e0191194</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0191194</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hagihara</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ariyoshi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kuroki</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Eguchi</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Higashi</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Mori</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title><italic>Clostridium butyricum</italic> enhances colonization resistance against <italic>Clostridioides difficile</italic> by metabolic and immune modulation</article-title>. <source>Sci. Rep.</source> <volume>11</volume>, <fpage>15007</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/S41598-021-94572-Z</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname> <given-names>S. J.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Kwon</surname> <given-names>B.</given-names>
</name>
<name>
<surname>You</surname> <given-names>H. J.</given-names>
</name>
<name>
<surname>Ko</surname> <given-names>G. P.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Vaginal lactobacilli inhibit growth and hyphae formation of <italic>Candida albicans</italic>
</article-title>. <source>Sci. Rep.</source> <volume>9</volume>, <fpage>8121</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/S41598-019-44579-4</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawai</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Yamagishi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Mikamo</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title><italic>In vitro</italic> efficacy of liposomal amphotericin b, micafungin and fluconazole against non-<italic>albicans candida</italic> species biofilms</article-title>. <source>J. Infect. Chemother.</source> <volume>21</volume>, <fpage>647</fpage>&#x2013;<lpage>653</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jiac.2015.05.007</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kawai</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Yamagishi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Mikamo</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Time-lapse tracking of <italic>Candida tropicalis</italic> biofilm formation and the antifungal efficacy of liposomal amphotericin</article-title>. <source>B. Jpn. J. Infect. Dis.</source> <volume>70</volume>, <fpage>559</fpage>&#x2013;<lpage>564</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7883/yoken.JJID.2016.574</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>Y. G.</given-names>
</name>
<name>
<surname>Khadke</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Antibiofilm and antifungal activities of medium-chain fatty acids against <italic>Candida albicans via</italic> mimicking of the quorum-sensing molecule farnesol</article-title>. <source>Microb. Biotechnol.</source> <volume>14</volume>, <fpage>1353</fpage>&#x2013;<lpage>1366</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/1751-7915.13710</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lohse</surname> <given-names>M. B.</given-names>
</name>
<name>
<surname>Gulati</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>A. D.</given-names>
</name>
<name>
<surname>Nobile</surname> <given-names>C. J.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Development and regulation of single- and multi-species <italic>Candida albicans</italic> biofilms</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>16</volume>, <fpage>19</fpage>&#x2013;<lpage>31</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/NRMICRO.2017.107</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacAlpine</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Daniel-Ivad</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Yano</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Revie</surname> <given-names>N. M.</given-names>
</name>
<name>
<surname>Todd</surname> <given-names>R. T.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>A small molecule produced by <italic>Lactobacillus</italic> species blocks <italic>Candida albicans</italic> filamentation by inhibiting a DYRK1-family kinase</article-title>. <source>Nat. Commun.</source> <volume>12</volume>, <fpage>6151</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/S41467-021-26390-W</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsubara</surname> <given-names>V. H.</given-names>
</name>
<name>
<surname>Bandara</surname> <given-names>H. M. H. N.</given-names>
</name>
<name>
<surname>Mayer</surname> <given-names>M. P. A.</given-names>
</name>
<name>
<surname>Samaranayake</surname> <given-names>L. P.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Probiotics as antifungals in mucosal candidiasis</article-title>. <source>Clin. Infect. Dis.</source> <volume>62</volume>, <fpage>1143</fpage>&#x2013;<lpage>1153</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/CID/CIW038</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsuda</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Sugita</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Ogishima</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Takeda</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Culture supernatants of lactobacillus gasseri and l. crispatus inhibit candida albicans biofilm formation and adhesion to HeLa cells</article-title>. <source>Mycopathologia</source> <volume>183</volume>, <fpage>691</fpage>&#x2013;<lpage>700</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11046-018-0259-4</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsumoto</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Yamagishi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Miyamoto</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Oka</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Takahashi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Mikamo</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Characterization of the vaginal microbiota of Japanese women</article-title>. <source>Anaerobe</source> <volume>54</volume>, <fpage>172</fpage>&#x2013;<lpage>177</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/J.ANAEROBE.2018.10.001</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maza</surname> <given-names>P. K.</given-names>
</name>
<name>
<surname>Bonfim-Melo</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Padovan</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Mortara</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Orikaza</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Ramos</surname> <given-names>L. M. D.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title><italic>Candida albicans</italic>: the ability to invade epithelial cells and survive under oxidative stress is unlinked to hyphal length</article-title>. <source>Front. Microbiol.</source> <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2017.01235</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mogavero</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sauer</surname> <given-names>F. M.</given-names>
</name>
<name>
<surname>Brunke</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Allert</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Schulz</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Wisgott</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Candidalysin delivery to the invasion pocket is critical for host epithelial damage induced by <italic>Candida albicans</italic>
</article-title>. <source>Cell. Microbiol.</source> <volume>23</volume>, <elocation-id>e13378</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cmi.13378</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moyes</surname> <given-names>D. L.</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Richardson</surname> <given-names>J. P.</given-names>
</name>
<name>
<surname>Mogavero</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>S. X.</given-names>
</name>
<name>
<surname>Wernecke</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Candidalysin is a fungal peptide toxin critical for mucosal infection</article-title>. <source>Nature</source> <volume>532</volume>, <fpage>64</fpage>&#x2013;<lpage>68</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/NATURE17625</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mukherjee</surname> <given-names>P. K.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Munyon</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ghannoum</surname> <given-names>M. A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title><italic>Candida</italic> biofilm: a well-designed protected environment</article-title>. <source>Med. Mycol.</source> <volume>43</volume>, <fpage>191</fpage>&#x2013;<lpage>208</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/13693780500107554</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nobile</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Nett</surname> <given-names>J. E.</given-names>
</name>
<name>
<surname>Andes</surname> <given-names>D. R.</given-names>
</name>
<name>
<surname>Mitchell</surname> <given-names>A. P.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Function of <italic>Candida albicans</italic> adhesin Hwp1 in biofilm formation</article-title>. <source>Eukaryot Cell.</source> <volume>5</volume>, <fpage>1604</fpage>&#x2013;<lpage>1610</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/EC.00194-06</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nunn</surname> <given-names>K. L.</given-names>
</name>
<name>
<surname>Clair</surname> <given-names>G. C.</given-names>
</name>
<name>
<surname>Adkins</surname> <given-names>J. N.</given-names>
</name>
<name>
<surname>Engbrecht</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Fillmore</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Forney</surname> <given-names>L. J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Amylases in the human vagina</article-title>. <source>mSphere</source> <volume>5</volume>, <fpage>e00943</fpage>&#x2013;<lpage>e00920</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mSphere.00943-20</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravel</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Brotman</surname> <given-names>R. M.</given-names>
</name>
<name>
<surname>Gajer</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Nandy</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Fadrosh</surname> <given-names>D. W.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis</article-title>. <source>Microbiome</source> <volume>1</volume>, <elocation-id>29</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/2049-2618-1-29</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ravel</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Gajer</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Abdo</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Schneider</surname> <given-names>G. M.</given-names>
</name>
<name>
<surname>Koenig</surname> <given-names>S. S. K.</given-names>
</name>
<name>
<surname>McCulle</surname> <given-names>S. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Vaginal microbiome of reproductive-age women</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A. 108 Supplement</source> <volume>1</volume>, <fpage>4680</fpage>&#x2013;<lpage>4687</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/PNAS.1002611107</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ribeiro</surname> <given-names>F. C.</given-names>
</name>
<name>
<surname>de Barros</surname> <given-names>P. P.</given-names>
</name>
<name>
<surname>Rossoni</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>Junqueira</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Jorge</surname> <given-names>A. O. C.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title><italic>Lactobacillus rhamnosus</italic> inhibits <italic>Candida albicans</italic> virulence factors <italic>in vitro</italic> and modulates immune system in <italic>Galleria mellonella</italic>
</article-title>. <source>J. Appl. Microbiol.</source> <volume>122</volume>, <fpage>201</fpage>&#x2013;<lpage>211</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/JAM.13324</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodr&#xed;guez-Cerdeira</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Mart&#xed;nez-Herrera</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Carnero-Gregorio</surname> <given-names>M.</given-names>
</name>
<name>
<surname>L&#xf3;pez-Barcenas</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Fabbrocini</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Fida</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Pathogenesis and clinical relevance of <italic>Candida</italic> biofilms in vulvovaginal candidiasis</article-title>. <source>Front. Microbiol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2020.544480</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roselletti</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Monari</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Sabbatini</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Perito</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Vecchiarelli</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Sobel</surname> <given-names>J. D.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>A role for yeast/pseudohyphal cells of <italic>Candida albicans</italic> in the correlated expression of NLRP3 inflammasome inducers in women with acute vulvovaginal candidiasis</article-title>. <source>Front. Microbiol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2019.02669</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossoni</surname> <given-names>R. D.</given-names>
</name>
<name>
<surname>dos Santos Velloso</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Figueiredo</surname> <given-names>L. M. A.</given-names>
</name>
<name>
<surname>Martins</surname> <given-names>C. P.</given-names>
</name>
<name>
<surname>Jorge</surname> <given-names>A. O. C.</given-names>
</name>
<name>
<surname>Junqueira</surname> <given-names>J. C.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Clinical strains of <italic>Lactobacillus</italic> reduce the filamentation of <italic>Candida albicans</italic> and protect <italic>Galleria mellonella</italic> against experimental candidiasis</article-title>. <source>Folia Microbiol. (Praha).</source> <volume>63</volume>, <fpage>307</fpage>&#x2013;<lpage>314</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/S12223-017-0569-9</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabbatini</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Visconti</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Gentili</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lusenti</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Nunzi</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Ronchetti</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title><italic>Lactobacillus iners</italic> cell-free supernatant enhances biofilm formation and hyphal/pseudohyphal growth by <italic>Candida albicans</italic> vaginal isolates</article-title>. <source>Microorganisms</source> <volume>9</volume>, <elocation-id>2577</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms9122577</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakagami</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Kawano</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Yamashita</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Yamada</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Fujino</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Kaeriyama</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Antifungal susceptibility trend and analysis of resistance mechanism for <italic>Candida</italic> species isolated from bloodstream at a Japanese university hospital</article-title>. <source>J. Infect. Chemother.</source> <volume>25</volume>, <fpage>34</fpage>&#x2013;<lpage>40</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jiac.2018.10.007</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Santos</surname> <given-names>I. D. C.</given-names>
</name>
<name>
<surname>Fran&#xe7;a</surname> <given-names>R. Y.</given-names>
</name>
<name>
<surname>Campos</surname> <given-names>D. L. C.</given-names>
</name>
<name>
<surname>Bomfim</surname> <given-names>Q. M. R.</given-names>
</name>
<name>
<surname>Melo</surname> <given-names>O. B.</given-names>
</name>
<name>
<surname>Holanda</surname> <given-names>A. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Antifungal and antivirulence activity of vaginal lactobacillus spp. products against <italic>Candida</italic> vaginal isolates</article-title>. <source>Pathog. (Basel Switzerland).</source> <volume>8</volume>, <elocation-id>150</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/pathogens8030150</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Rodrigues</surname> <given-names>C. F.</given-names>
</name>
<name>
<surname>Ara&#xfa;jo</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Rodrigues</surname> <given-names>M. E.</given-names>
</name>
<name>
<surname>Henriques</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title><italic>Candida</italic> species biofilms&#x2019; antifungal resistance</article-title>. <source>J. Fungi (Basel)</source> <volume>3</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/JOF3010008</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spear</surname> <given-names>G. T.</given-names>
</name>
<name>
<surname>French</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Gilbert</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Zariffard</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Mirmonsef</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Sullivan</surname> <given-names>T. H.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Human &#x3b1;-amylase present in lower-genital-tract mucosal fluid processes glycogen to support vaginal colonization by <italic>Lactobacillus</italic>
</article-title>. <source>J. Infect. Dis.</source> <volume>210</volume>, <fpage>1019</fpage>&#x2013;<lpage>1028</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/infdis/jiu231</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sudbery</surname> <given-names>P. E.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Growth of <italic>Candida albicans</italic> hyphae</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>9</volume>, <fpage>737</fpage>&#x2013;<lpage>748</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/NRMICRO2636</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talapko</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Juzba&#x161;i&#x107;</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Matijevi&#x107;</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Pustijanac</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Beki&#x107;</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kotris</surname> <given-names>I.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Candida albicans&#x2013;the virulence factors and clinical manifestations of infection</article-title>. <source>J. Fungi.</source> <volume>7</volume>, <elocation-id>79</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/jof7020079</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Zhuang</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Antimicrobial compounds produced by vaginal <italic>Lactobacillus crispatus</italic> are able to strongly inhibit <italic>Candida albicans</italic> growth, hyphal formation and regulate virulence-related gene expressions</article-title>. <source>Front. Microbiol.</source> <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/FMICB.2017.00564</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weber</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Sohr</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Schulz</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Fleischhacker</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ruhnke</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Secretion of E,E-farnesol and biofilm formation in eight different <italic>Candida</italic> species. antimicrob</article-title>. <source>Agents Chemother.</source> <volume>52</volume>, <fpage>1859</fpage>&#x2013;<lpage>1861</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.01646-07</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willems</surname> <given-names>H. M. E.</given-names>
</name>
<name>
<surname>Ahmed</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Peters</surname> <given-names>B. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Vulvovaginal candidiasis: a current understanding and burning questions</article-title>. <source>J. Fungi (Basel)</source> <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/JOF6010027</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Witkin</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Mendes-Soares</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Linhares</surname> <given-names>I. M.</given-names>
</name>
<name>
<surname>Jayaram</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ledger</surname> <given-names>W. J.</given-names>
</name>
<name>
<surname>Forney</surname> <given-names>L. J.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Influence of vaginal bacteria and d- and l-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections</article-title>. <source>mBio</source> <volume>4</volume>, <fpage>e00460</fpage>&#x2013;<lpage>e00413</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.00460-13</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamagishi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Terada</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ohki</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Mikamo</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Antifungal susceptibility of <italic>Candida</italic> species isolated from patient with invasive fungal peritonitis and investigation on clinical breakpoints of itraconazole</article-title>. <source>Jpn. J. Antibiot.</source> <volume>62</volume>, <fpage>415</fpage>&#x2013;<lpage>434</lpage>.</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yano</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Sobel</surname> <given-names>J. D.</given-names>
</name>
<name>
<surname>Nyirjesy</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Sobel</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>V. L.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Q.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes</article-title>. <source>BMC Womens Health</source> <volume>19</volume>, <elocation-id>48</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12905-019-0748-8</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Hansmann</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>C. C.</given-names>
</name>
<name>
<surname>Suzuki</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Sch&#xfc;tte</surname> <given-names>U.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>The vaginal bacterial communities of Japanese women resemble those of women in other racial groups</article-title>. <source>FEMS Immunol. Med. Microbiol.</source> <volume>58</volume>, <fpage>169</fpage>&#x2013;<lpage>181</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1574-695X.2009.00618.x</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Filler</surname> <given-names>S. G.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Interactions of <italic>Candida albicans</italic> with epithelial cells</article-title>. <source>Cell Microbiol.</source> <volume>12</volume>, <fpage>273</fpage>&#x2013;<lpage>282</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1462-5822.2009.01412.x</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>
